Yahoo Web Search

  1. About 40% of patients who received a combination of Bristol-Myers Squibb Co's immuno-oncology drugs Opdivo and Yervoy as an initial treatment for advanced non-small cell ...

  2. In this article, we will take a closer look at hedge fund sentiment towards Bristol-Myers Squibb Company (NYSE:BMY). Bristol-Myers Squibb Company ...

  3. They were Bristol-Myers Squibb's (NYSE:BMY) $74 billion buyout of Celgene and AbbVie's (NYSE:ABBV) $63 billion acquisition of Allergan. "Life sciences CEOs realize that ...

  4. Nektar Therapeutics NKTR updated preliminary data from one cohort of the phase I/II PIVOT-02 study, evaluating its immuno-oncology candidate, bempegaldesleukin, in combination with Bristol ...

  5. A2A Pharmaceuticals Appoints New Advisors

    Associated Press via Yahoo FinanceSep 30 12:00 PM

    Prior leadership roles have included the head of global research and development and executive vice president global development and medical at Merck Serono, and several senior positions at ...

  6. T. Rowe Price Equity Income Fund Semi-Annual Letter 2019

    GuruFocus.com via Yahoo FinanceSep 25 23:25 PM

    Overseas equity markets were also strong, while bond prices rose as longer-term interest rates fell to their lowest levels since late 2016. Investors seemed most relieved by a dovish pivot in ...

  7. Pfizer PFE and its Germany-based partner Merck KGaA announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) recommended approval of ...

  8. Coherus Biosciences Inc (NASDAQ: CHRS) The Medicines Company (NASDAQ: MDCO) (Biotech stocks that hit 52-week lows Sept.

  9. This move outpaced the S&P 500's daily loss of 0.45%. This has outpaced the Medical sector's loss of 1.24% and the S&P 500's gain of 0.59% in that time. Meanwhile, our latest consensus estimate ...

  10. Five Prime Therapeutics Inc (NASDAQ: FPRX): initial Phase 1 data for FPA150 in solid tumors (Sept. Agios Pharmaceuticals Inc (NASDAQ: AGIO): already released Phase 3 data for AG-120 Ivosidenib ...

  1. Ads
    related to BRISTOL-MYERS SQUIBB COMPANY